05/15/2024
7:32 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:32 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
11:24 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
11:35 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:23 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:05 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
10:39 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/18/2024
4:09 PM | Corcept Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form ARS | |
04/17/2024
5:05 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
6:00 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form DEF 14A | |
04/08/2024
5:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
11:40 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
7:00 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:38 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
9:03 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
1:12 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
1:32 PM | Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A | |
03/27/2024
12:01 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:09 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:14 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:02 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:03 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:09 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:41 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:24 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:11 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
7:06 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
11:12 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:17 PM | Corcept Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
2:45 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:23 PM | BAKER G LEONARD JR (Filed by)
Corcept Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
7:47 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:59 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:08 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:20 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:38 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:40 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
41 banks launch ‘crypto dollar’ (Ad) Everyone knows the US financial system is in the middle of a radical change...
The White House wants an all-digital dollar.
Plus at least 41 major banks (see if your bank is one of them right here). Here's how you capitalize (including #1 crypto to play it). |
02/13/2024
9:04 AM | Corcept Therapeutics (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
7:12 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/12/2024
6:51 PM | BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
4:39 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
1:17 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
7:06 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:06 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:14 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
10:24 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
7:06 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
6:29 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
11:09 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
5:21 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:31 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:46 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:34 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:56 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
2:02 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
5:56 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:58 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:59 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
6:00 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:53 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:54 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
5:23 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
11:08 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
9:27 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
6:55 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
5:49 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
5:32 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
5:14 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
10:55 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
10:29 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
10:21 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/12/2023
7:19 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:36 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:26 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:19 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
12:50 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
11:59 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
12:17 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
5:06 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
5:07 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
2:19 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
10:27 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
5:12 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:04 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:41 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:06 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:15 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
41 banks launch ‘crypto dollar’ (Ad) Everyone knows the US financial system is in the middle of a radical change...
The White House wants an all-digital dollar.
Plus at least 41 major banks (see if your bank is one of them right here). Here's how you capitalize (including #1 crypto to play it). |
09/06/2023
5:21 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:55 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
9:07 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
1:37 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
12:16 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023
5:03 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
5:24 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:53 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:35 PM | Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
| Form 144/A | |
